Home
/
Regenerative Medical Technology Group Inc.
/
Financials
/
Quarterly
Regenerative Medical Technology Group Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Regenerative Medical Technology Group Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.18M
Nov 19, 2025
Q2
2025
Jun 30, 2025
$983.5K
Aug 19, 2025
Q1
2025
Mar 31, 2025
$1.36M
May 20, 2025
Q3
2025
Sep 30, 2024
$986.3K
Nov 19, 2025
Q2
2025
Jun 30, 2024
$793.3K
Aug 19, 2025
Q1
2025
Mar 31, 2024
$817.0K
May 20, 2025
Q3
2023
Sep 30, 2023
$646.8K
Nov 20, 2023
Q2
2024
Jun 30, 2023
$361.4K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$786.2K
May 20, 2024
Q3
2023
Sep 30, 2022
$367.7K
Nov 20, 2023
Q2
2023
Jun 30, 2022
$297.5K
Aug 9, 2023
Q1
2023
Mar 31, 2022
$298.7K
May 22, 2023
Q2
2022
Dec 31, 2021
$20.2K
Aug 15, 2022
Q1
2022
Dec 31, 2021
$4.4K
May 19, 2022
Q3
2022
Sep 30, 2021
$165.0K
Nov 9, 2022
Q2
2022
Jun 30, 2021
$15.8K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$4.4K
May 19, 2022
Q3
2021
Sep 30, 2020
$12.3K
Dec 22, 2021
Q2
2021
Jun 30, 2020
$28.8K
Aug 13, 2021
Q1
2021
Mar 31, 2020
$11.3K
May 17, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.35M)
Nov 19, 2025
Q2
2025
Jun 30, 2025
($1.31M)
Aug 19, 2025
Q1
2025
Mar 31, 2025
($760.0K)
May 20, 2025
Q3
2025
Sep 30, 2024
($887.1K)
Nov 19, 2025
Q2
2025
Jun 30, 2024
($2.08M)
Aug 19, 2025
Q1
2025
Mar 31, 2024
($1.96M)
May 20, 2025
Q3
2023
Sep 30, 2023
($5.86M)
Nov 20, 2023
Q2
2024
Jun 30, 2023
($2.03M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($1.67M)
May 20, 2024
Q3
2023
Sep 30, 2022
($1.34M)
Nov 20, 2023
Q2
2023
Jun 30, 2022
($1.49M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($1.68M)
May 22, 2023
Q3
2022
Sep 30, 2021
($9.92M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($926.1K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($472.3K)
May 19, 2022
Q3
2021
Sep 30, 2020
($7.41M)
Dec 22, 2021
Q2
2021
Jun 30, 2020
($3.39M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($846.3K)
May 17, 2021
Q3
2020
Sep 30, 2019
($1.73M)
Feb 24, 2021
Q2
2020
Jun 30, 2019
$2.94M
Feb 8, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($445.8K)
Nov 19, 2025
Q2
2025
Jun 30, 2025
($250.1K)
Aug 19, 2025
Q1
2025
Mar 31, 2025
$135.0K
May 20, 2025
Q3
2025
Sep 30, 2024
$19.6K
Nov 19, 2025
Q2
2025
Jun 30, 2024
($214.0K)
Aug 19, 2025
Q1
2025
Mar 31, 2024
($105.1K)
May 20, 2025